These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 655003)

  • 1. Properties of platelet phospholipase A2.
    Schoene NW
    Adv Prostaglandin Thromboxane Res; 1978; 3():121-6. PubMed ID: 655003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.
    Bills TK; Smith JB; Silver MJ
    J Clin Invest; 1977 Jul; 60(1):1-6. PubMed ID: 874074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
    Blackwell GJ; Duncombe WG; Flower RJ; Parsons MF; Vane JR
    Br J Pharmacol; 1977 Feb; 59(2):353-66. PubMed ID: 837023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis.
    Han X; Gubitosi-Klug RA; Collins BJ; Gross RW
    Biochemistry; 1996 May; 35(18):5822-32. PubMed ID: 8639543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).
    Makheja AN; Bailey JM
    Prostaglandins Leukot Med; 1982 Jun; 8(6):653-60. PubMed ID: 6810384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A
    Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic modulation of platelet phospholipase A2 activity and platelet aggregation by mepacrine (quinacrine).
    Chan AC; Pritchard ET; Gerrard JM; Man RY; Choy PC
    Biochim Biophys Acta; 1982 Oct; 713(1):170-2. PubMed ID: 7138896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids.
    Broekman MJ; Ward JW; Marcus AJ
    J Clin Invest; 1980 Aug; 66(2):275-83. PubMed ID: 7400315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets.
    Walenga RW; Opas EE; Feinstein MB
    J Biol Chem; 1981 Dec; 256(23):12523-8. PubMed ID: 6795206
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
    Lösche W; Michel E; Thielmann K; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2 and platelet aggregation.
    Blackwell GJ
    Adv Prostaglandin Thromboxane Res; 1978; 3():137-42. PubMed ID: 655004
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of different physical states of phospholipid substrates on partially purified platelet phospholipase A2 activity.
    Kannagi R; Koizumi K
    Biochim Biophys Acta; 1979 Oct; 556(3):423-33. PubMed ID: 486471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative loss of individual eicosapentaenoyl-relative to arachidonoyl-containing phospholipids in thrombin-stimulated human platelets.
    Mahadevappa VG; Holub BJ
    J Lipid Res; 1987 Nov; 28(11):1275-80. PubMed ID: 2828497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited hydrolysis of platelet membrane phospholipids. On the proposed phospholipase-susceptible domain in platelet membranes.
    Kannagi R; Koizumi K; Masuda T
    J Biol Chem; 1981 Feb; 256(3):1177-84. PubMed ID: 7451497
    [No Abstract]   [Full Text] [Related]  

  • 16. Phospholipase A1 acting on phosphatidic acid in porcine platelet membranes.
    Inoue M; Okuyama H
    J Biol Chem; 1984 Apr; 259(8):5083-6. PubMed ID: 6715338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid.
    Dise CA; Burch JW; Goodman DB
    J Biol Chem; 1982 May; 257(9):4701-4. PubMed ID: 6802839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic adenosine 3',5'-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets.
    Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecases P
    Biochem Biophys Res Commun; 1977 Jun; 76(3):828-35. PubMed ID: 197928
    [No Abstract]   [Full Text] [Related]  

  • 19. Acyl specificity of phospholipases A2 and C in thrombin-stimulated human platelets.
    Tsegaye Y; Daasvatn KO; Holmsen H
    Platelets; 2002 Feb; 13(1):31-5. PubMed ID: 11918834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes.
    Lagarde M; Menashi S; Crawford N
    FEBS Lett; 1981 Feb; 124(1):23-6. PubMed ID: 7215552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.